Lysophosphatidic acid–mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci193364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Daisuke Yasuda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Akita University Graduate School of Medicine, Akita, Japan. Hauptthemen laut MEDLINE: Lysophospholipids, Forkhead Transcription Factors, NF-kappa B, Lymphatic Vessels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, The Japan Agency for Medical Research and Development, The Takeda Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Akita University Graduate School of Medicine, Akita, Japan.
- Department of Lipid Life Science, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- Department of Molecular Biology, The Jikei University School of Medicine, Tokyo, Japan.
- Division of Pharmacology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
- Department of Medical Lipid Science, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Medical Biology, Akita University Graduate School of Medicine, Akita, Japan.
Förderung
- Japan Society for the Promotion of Science
- The Japan Agency for Medical Research and Development
- The Takeda Science Foundation
- The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care
- The Mochida Memorial Foundation for Medical and Pharmaceutical Research
- The Suzuken Memorial Foundation
- The SENSHIN Medical Research Foundation
- The Association for Research on Lactic Acid Bacteria
Zitieren
APA
Yasuda, D., Sato, N., Yanagida, K., Hashidate-Yoshida, T., Shiiya, T., Shindou, H., Taira, A., Ebihara, T., Shimizu, T., Hirashima, M., Mizuno, S., Takahashi, S., & Ishii, S. (2026). Lysophosphatidic acid–mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development. Journal of Clinical Investigation. https://doi.org/10.1172/jci193364
Vancouver
Yasuda D, Sato N, Yanagida K, Hashidate-Yoshida T, Shiiya T, Shindou H, et al. Lysophosphatidic acid–mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development. Journal of Clinical Investigation. 2026. doi:10.1172/jci193364
BibTeX
@article{Yasuda2026,
author = {Yasuda, Daisuke and Sato, Nana and Yanagida, Keisuke and Hashidate-Yoshida, Tomomi and Shiiya, Tomohiro and Shindou, Hideo and Taira, Atsuki and Ebihara, Takashi and Shimizu, Takao and Hirashima, Masanori and Mizuno, Seiya and Takahashi, Satoru and Ishii, Satoshi},
title = {Lysophosphatidic acid–mediated NF-κB activation promotes FOXC2 expression essential for lymphatic valve development},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci193364}
}
EUVIMED